Home > Resources > Company Profiles > Stryker Corporation

Stryker Corporation (SYK)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Stephen P. MacMillan , CEO/President/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Stephen P. MacMillan, CEO/President/Director

2825 Airview Boulevard

Kalamazoo, MI 49002

US Map it

Phone: (269) 385-2600

Fax: (269) 385-1062

www.stryker.com



Overview

A medical technology company with the range of products in orthopaedics and a presence in other medical specialties.

Employees

Number of Employees: 16,026
Revenue per Employee: $319,074

Top Executives

Michael W. Rude, Divisional Vice President
Thomas R. Winkel, Vice President/Secretary
Dean H. Bergy, CFO/Vice President

Curtis E. Hall, Vice President/General Counsel
Stephen Si Johnson, Divisional President/Vice President
Luciano Cattani, Executive VP, Divisional

James E. Kemler, Divisional President/Vice President

Board of Directors

William U. Parfet, Director
Thomas R. Winkel, Vice President/Secretary
Howard E. Cox, Jr., Director

John W. Brown, Chairman of the Board/Director
Donald M. Engelman, Ph.D., Director
Ronda E. Stryker, Director

Financials

Quarterly
Annual

Income Statement 07/2008 04/2008 01/2008 10/2007
Sales 444.5 Mil. 412.9 Mil. 439 Mil. 392.3 Mil.
Gross Operating Profit 1.27 Bil. 1.22 Bil. 1.22 Bil. 1.06 Bil.
Operating Income before D & A (EBITDA) 499.6 Mil. 481.9 Mil. 458.4 Mil. 381.2 Mil.
Total Income Before Interest Expenses (EBIT) 420.1 Mil. 404 Mil. 384 Mil. 317.9 Mil.
Total Net Income 305.8 Mil. 290.5 Mil. 276.1 Mil. 228.7 Mil.
Basic EPS, Total 0.74 0.71 0.67 0.56
Diluted EPS, Total 0.73 0.7 0.66 0.55

BALANCE STATEMENT 07/2008 04/2008 01/2008 10/2007
Cash and Equivalents 421.6 Mil. 423.5 Mil. 290.5 Mil. 170.9 Mil.
Total Assets 5.35 Bil. 5.06 Bil. 4.9 Bil. 4.44 Bil.
Total Liabilities 1.12 Bil. 1.15 Bil. 1.33 Bil. 1.09 Bil.
Total Capitalization 6.22 Bil. 5.93 Bil. 5.38 Bil. 5.16 Bil.

Cash Flow 07/2008 04/2008 01/2008 10/2007
Net Cash From Continuing Operations 431.1 Mil. 190.8 Mil. NA 701.4 Mil.
Net Cash From Investing Activities -191 Mil. 54.6 Mil. -1.18 Bil. -897.8 Mil.
Net Cash From Financing Activities -123.5 Mil. -130.3 Mil. 13.6 Mil. -16.8 Mil.
Net Change in Cash & Cash Equivalents 131.1 Mil. 133 Mil. -126.1 Mil. -245.7 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 1.54 Bil. 1.56 Bil. 1.47 Bil. 1.31 Bil.
Gross Operating Profit 4.46 Bil. 3.85 Bil. 3.4 Bil. 2.96 Bil.
Operating Income before D & A (EBITDA) 1.69 Bil. 1.46 Bil. 1.3 Bil. 1.09 Bil.
Total Income Before Interest Expenses (EBIT) 1.37 Bil. 1.1 Bil. 1 Bil. 723.8 Mil.
Total Net Income 1.02 Bil. 777.7 Mil. 675.2 Mil. 465.7 Mil.
Basic EPS, Total 2.48 1.91 1.67 1.16
Diluted EPS, Total 2.44 1.89 1.64 1.14

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 290.5 Mil. 416.6 Mil. 491.2 Mil. 349.4 Mil.
Total Assets 4.9 Bil. 3.53 Bil. 2.87 Bil. 2.14 Bil.
Total Liabilities 1.33 Bil. 1.35 Bil. 1.25 Bil. 1.11 Bil.
Total Capitalization 5.38 Bil. 4.19 Bil. 3.44 Bil. 2.75 Bil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations NA 867.3 Mil. 863.8 Mil. 593.3 Mil.
Net Cash From Investing Activities -1.18 Bil. -742.3 Mil. -903 Mil. -324 Mil.
Net Cash From Financing Activities 13.6 Mil. -203.2 Mil. 201.9 Mil. 10.6 Mil.
Net Change in Cash & Cash Equivalents -126.1 Mil. -74.6 Mil. 141.8 Mil. 283.5 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
Covidien Limited
21.16 Bil.
Becton, Dickinson & Company
21.14 Bil.
Boston Scientific Corporation
17.65 Bil.
Baxter International, Incorporated
38.68 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented